AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vognova GM 1 Tablet ER

Prescription Icon
Prescription Required

Marketer

Astranova Biotech

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Vognova GM 1 Tablet ER

Diabex Duo ER tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. They help manage blood glucose levels. Diabex Duo ER should be taken with meals, consistently at the same time daily for optimal effect. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue taking this medication even if feeling well or experiencing controlled blood sugar; abrupt cessation without consulting your doctor can lead to elevated blood glucose, increasing the risk of kidney complications, vision loss, neuropathy, and limb loss. Remember, this medication is part of a comprehensive program including diet, exercise, and weight management as advised by your doctor. Lifestyle choices are crucial for diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption should be minimized due to increased hypoglycemia risk. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling, blurry vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Inform your physician of any heart history before starting this medication; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor. Regular blood glucose monitoring, along with blood tests to track blood cell counts and liver function, will be necessary.

Uses of Vognova GM 1 Tablet ER

Managing type 2 diabetes

Major Benefits of Vognova GM 1 Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vognova GM 1 Tablet ER on an empty stomach.

Common Side effects of Vognova GM 1 Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Vognova GM 1 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vognova GM 1 Tablet ER should be taken on an empty stomach.

How Vognova GM 1 Tablet ER works:

Vognova GM 1 Extended-Release tablet comprises a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vognova GM 1 Tablet ER and alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Vognova GM 1 Tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vognova GM 1 tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Vognova GM 1 Tablet ER carries a high risk for individuals with kidney impairment and should be strictly avoided. Medical advice is essential. Furthermore, its use is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Vognova GM 1 Tablet ER cautiously, potentially requiring dose modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, Vognova GM 1 Tablet ER is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Vognova GM 1 Tablet ER :

Should you forget to take a Vognova GM 1 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vognova GM 1 Tablet ER

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Vognova GM 1 Tablet ER

Vognova GM 1 Extended-Release tablet combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This regimen enhances blood glucose control when used with dietary adjustments and physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar levels. This formulation is unsuitable for type 1 diabetes.
Taking Vognova GM 1 Tablet ER may cause common side effects such as low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal pain, headache, skin rash, and respiratory illness.
Patients with hypersensitivity to Vognova GM 1 Tablet ER ingredients or inactive substances should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Vognova GM 1 Tablet ER is unsafe. This combination can reduce blood sugar to dangerously low levels (hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Vognova GM 1 Tablet ER can induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. These are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or concomitant antidiabetic medications are used. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the package or label. Discard any leftover medication. Prevent access by children, animals, and other individuals.
Vognova GM 1 Tablet ER
119
MRP 145
17% off